Annual CFI
-$649.12 M
-$616.34 M-1880.40%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual cash flow from investing activities is currently -$649.12 million, with the most recent change of -$616.34 million (-1880.40%) on 31 December 2023. During the last 3 years, it has fallen by -$612.70 million (-1682.55%). AMPH annual CFI is now -6061.52% below its all-time high of -$10.54 million, reached on 31 December 2011.AMPH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$34.59 M
+$35.32 M+50.52%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly cash flow from investing activities is currently -$34.59 million, with the most recent change of +$35.32 million (+50.52%) on 30 September 2024. Over the past year, it has dropped by -$3.43 million (-11.02%). AMPH quarterly CFI is now -326.99% below its all-time high of $15.24 million, reached on 31 March 2024.AMPH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$192.30 M
-$3.43 M-1.82%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM cash flow from investing activities is currently -$192.30 million, with the most recent change of -$3.43 million (-1.82%) on 30 September 2024. Over the past year, it has increased by +$354.00 million (+64.80%). AMPH TTM CFI is now -2599.72% below its all-time high of -$7.12 million, reached on 31 March 2013.AMPH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1880.4% | -11.0% | +64.8% |
| 3 y3 years | -1682.5% | -817.6% | -565.5% |
| 5 y5 years | -1438.8% | -85.7% | -270.0% |
AMPH Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2163.9% | at low | -327.0% | +93.2% | -570.7% | +70.4% |
| 5 y | 5 years | -2163.9% | at low | -327.0% | +93.2% | -570.7% | +70.4% |
| alltime | all time | -6061.5% | at low | -327.0% | +93.2% | -2599.7% | +70.4% |
Amphastar Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$34.59 M(-50.5%) | -$192.30 M(+1.8%) |
| June 2024 | - | -$69.90 M(-558.8%) | -$188.87 M(-69.9%) |
| Mar 2024 | - | $15.24 M(-114.8%) | -$627.55 M(-3.3%) |
| Dec 2023 | -$649.12 M(+1880.4%) | -$103.05 M(+230.8%) | -$649.12 M(+18.8%) |
| Sept 2023 | - | -$31.15 M(-93.9%) | -$546.30 M(+3.0%) |
| June 2023 | - | -$508.58 M(+7930.7%) | -$530.40 M(+1668.0%) |
| Mar 2023 | - | -$6.33 M(+2665.5%) | -$30.00 M(-8.5%) |
| Dec 2022 | -$32.78 M(+14.3%) | -$229.00 K(-98.5%) | -$32.78 M(-26.3%) |
| Sept 2022 | - | -$15.26 M(+86.5%) | -$44.50 M(+34.8%) |
| June 2022 | - | -$8.18 M(-10.2%) | -$33.01 M(+13.5%) |
| Mar 2022 | - | -$9.11 M(-23.8%) | -$29.09 M(+1.4%) |
| Dec 2021 | -$28.67 M(-21.3%) | -$11.95 M(+217.2%) | -$28.67 M(-0.8%) |
| Sept 2021 | - | -$3.77 M(-11.4%) | -$28.89 M(-5.5%) |
| June 2021 | - | -$4.25 M(-51.1%) | -$30.58 M(-16.0%) |
| Mar 2021 | - | -$8.70 M(-28.6%) | -$36.39 M(-0.1%) |
| Dec 2020 | -$36.41 M(-27.9%) | -$12.18 M(+123.4%) | -$36.41 M(+15.3%) |
| Sept 2020 | - | -$5.45 M(-45.8%) | -$31.59 M(-29.4%) |
| June 2020 | - | -$10.07 M(+15.4%) | -$44.76 M(+0.9%) |
| Mar 2020 | - | -$8.72 M(+18.6%) | -$44.37 M(-12.2%) |
| Dec 2019 | -$50.53 M(+19.8%) | -$7.35 M(-60.5%) | -$50.53 M(-2.8%) |
| Sept 2019 | - | -$18.62 M(+92.6%) | -$51.97 M(+12.4%) |
| June 2019 | - | -$9.67 M(-35.0%) | -$46.23 M(-4.3%) |
| Mar 2019 | - | -$14.88 M(+69.2%) | -$48.33 M(+14.6%) |
| Dec 2018 | -$42.18 M | -$8.80 M(-31.7%) | -$42.18 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$12.88 M(+9.4%) | -$43.51 M(-0.2%) |
| June 2018 | - | -$11.77 M(+34.7%) | -$43.61 M(+9.9%) |
| Mar 2018 | - | -$8.74 M(-13.7%) | -$39.66 M(+7.5%) |
| Dec 2017 | -$36.89 M(-6.6%) | -$10.13 M(-21.9%) | -$36.89 M(+8.9%) |
| Sept 2017 | - | -$12.97 M(+65.7%) | -$33.87 M(-5.6%) |
| June 2017 | - | -$7.83 M(+31.2%) | -$35.87 M(-0.5%) |
| Mar 2017 | - | -$5.96 M(-16.1%) | -$36.05 M(-8.7%) |
| Dec 2016 | -$39.50 M(+133.4%) | -$7.11 M(-52.5%) | -$39.50 M(+7.2%) |
| Sept 2016 | - | -$14.96 M(+86.9%) | -$36.85 M(+44.0%) |
| June 2016 | - | -$8.01 M(-15.0%) | -$25.59 M(+20.1%) |
| Mar 2016 | - | -$9.42 M(+111.3%) | -$21.30 M(+25.8%) |
| Dec 2015 | -$16.93 M(-57.4%) | -$4.46 M(+20.4%) | -$16.93 M(-24.4%) |
| Sept 2015 | - | -$3.70 M(-0.5%) | -$22.39 M(+2.6%) |
| June 2015 | - | -$3.72 M(-26.3%) | -$21.82 M(-45.5%) |
| Mar 2015 | - | -$5.04 M(-49.2%) | -$40.02 M(+0.6%) |
| Dec 2014 | -$39.77 M(+117.4%) | -$9.93 M(+217.2%) | -$39.77 M(+20.5%) |
| Sept 2014 | - | -$3.13 M(-85.7%) | -$33.01 M(-5.6%) |
| June 2014 | - | -$21.92 M(+356.9%) | -$34.96 M(+118.9%) |
| Mar 2014 | - | -$4.80 M(+51.4%) | -$15.97 M(-12.7%) |
| Dec 2013 | -$18.30 M(-27.1%) | -$3.17 M(-37.6%) | -$18.30 M(+20.9%) |
| Sept 2013 | - | -$5.08 M(+73.4%) | -$15.13 M(+50.5%) |
| June 2013 | - | -$2.93 M(-58.9%) | -$10.05 M(+41.1%) |
| Mar 2013 | - | -$7.12 M | -$7.12 M |
| Dec 2012 | -$25.11 M(+138.4%) | - | - |
| Dec 2011 | -$10.54 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual CFI year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly CFI year-on-year change?
- What is Amphastar Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM CFI year-on-year change?
What is Amphastar Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AMPH is -$649.12 M
What is the all time high annual CFI for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash flow from investing activities is -$10.54 M
What is Amphastar Pharmaceuticals annual CFI year-on-year change?
Over the past year, AMPH annual cash flow from investing activities has changed by -$616.34 M (-1880.40%)
What is Amphastar Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AMPH is -$34.59 M
What is the all time high quarterly CFI for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash flow from investing activities is $15.24 M
What is Amphastar Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AMPH quarterly cash flow from investing activities has changed by -$3.43 M (-11.02%)
What is Amphastar Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AMPH is -$192.30 M
What is the all time high TTM CFI for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM cash flow from investing activities is -$7.12 M
What is Amphastar Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AMPH TTM cash flow from investing activities has changed by +$354.00 M (+64.80%)